A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth

Qing-yong Hu(North Sichuan Medical University), Yang Cao(Southwest University), Feng-tian Li(Sichuan University), Tao Deng(Sichuan University), Haibo Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Liu(Sichuan University), Yu-huang Li(Sichuan University), Lei Li(Shanxi Academy of Medical Sciences), Zhi‐Xiong Jim Xiao(Ministry of Education of the People's Republic of China)
Acta Pharmacologica Sinica
October 9, 2024
Cited by 5


Related Papers